InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Krempa David, Chief Business Officer. Officer active across 1 company, notably Eton Pharmaceuticals, Inc.. In total, 16 filings have been published. Split: 0 buy · 7 sells. Total volume traded: €4.4m. History available since 12 June 2025. The latest transaction was filed on 24 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Krempa David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
25,000 shares@ US$7.31Common StockSEC:0001437749-26-028846:0
25,000 shares@ US$65.07Common StockSEC:0001437749-26-028846:1
10,000 sharesCommon StockSEC:0001437749-26-023440:0
519 shares@ US$35.000.0010% mcap0.5% of flowCommon StockSEC:0001437749-26-018628:3
19,679 shares@ US$31.47390.034% mcap16.7% of flowCommon StockSEC:0001437749-26-018628:9
30,591 shares@ US$3.580.0061% mcap3.0% of flowCommon StockSEC:0001437749-26-018628:0
32,963 shares@ US$33.22080.061% mcap29.6% of flowCommon StockSEC:0001437749-26-018628:1
9,315 shares@ US$33.88020.018% mcap8.5% of flowCommon StockSEC:0001437749-26-018628:2
25,000 shares@ US$1.380.0019% mcap0.9% of flowCommon StockSEC:0001437749-26-018628:4
12,524 shares@ US$1.370.0010% mcap0.5% of flowCommon StockSEC:0001437749-26-018628:5
37,524 shares@ US$31.49270.065% mcap31.9% of flowCommon StockSEC:0001437749-26-018628:6
12,476 shares@ US$1.370.0009% mcap0.5% of flowCommon StockSEC:0001437749-26-018628:7
7,203 shares@ US$3.580.0014% mcap0.7% of flowCommon StockSEC:0001437749-26-018628:8
1,942 shares@ US$15.620.0017% mcap11.2% of flowCommon StockSEC:0001437749-26-001288:0
6,264 shares@ US$17.000.0058% mcap38.8% of flowCommon StockSEC:0001437749-25-037745:0
16,977 shares@ US$14.926.6% of flowCommon StockSEC:0001437749-25-020518:0
16 of 16 declarations
About Krempa David
Krempa David is Chief Business Officer at Eton Pharmaceuticals, Inc. He has 14 filings in total, and across the recent filings tracked, they cover the period from 2025-06-16 to 2026-07-13, with EUR 0 in purchases and EUR 2995614 in sales, the most frequent transaction nature being Levée d'options.
